Chemical inhibitors of TMTC2 can employ various strategies to reduce the activity of this protein by influencing the intracellular calcium levels and calcium signaling pathways upon which TMTC2 function depends. Calcium chloride, for example, increases intracellular calcium concentrations, which can lead to the inhibition of TMTC2 when excessive calcium triggers a shutdown of its activity. Similarly, BAPTA acts as a calcium chelator to lower intracellular calcium levels, thus potentially inhibiting TMTC2 if its function requires calcium binding or is regulated by calcium concentrations. Ruthenium Red and 2-Aminoethoxydiphenyl borate (2-APB) target calcium channels and IP3 receptors, respectively, to control calcium influx and release from internal stores, which may inhibit TMTC2 if it is part of a calcium-dependent signaling cascade.
In addition to direct calcium modulation, several chemicals target secondary messengers and enzymes that are critical for calcium-mediated signaling pathways. Bisindolylmaleimide I and U73122 suppress the activity of protein kinase C (PKC) and phospholipase C, respectively, which are both important for the activation of proteins downstream of calcium signaling. If TMTC2's activity is contingent upon PKC-mediated phosphorylation, inhibition of this enzyme will decrease TMTC2 function. Thapsigargin and Cyclopiazonic acid inhibit the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to ER calcium store depletion, which may inhibit TMTC2 by disrupting its calcium homeostasis. ML-7, by inhibiting myosin light chain kinase (MLCK), could downregulate TMTC2 if its activity is intertwined with cytoskeletal dynamics controlled by MLCK. W-7, a calmodulin inhibitor, can also inhibit TMTC2 by blocking calmodulin-dependent regulatory mechanisms. Lastly, SKF-96365 and Xestospongin C, which inhibit receptor-mediated calcium entry channels and the IP3 receptor, respectively, further demonstrate the potential to inhibit TMTC2 by hampering essential components of the calcium signaling mechanisms that might regulate its function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Calcium chloride anhydrous | 10043-52-4 | sc-207392 sc-207392A | 100 g 500 g | $65.00 $262.00 | 1 | |
Calcium chloride can increase intracellular calcium levels, which could lead to the inhibition of TMTC2 if its function is calcium-sensitive and if excessive calcium leads to the shutdown of its activity. | ||||||
Ruthenium red | 11103-72-3 | sc-202328 sc-202328A | 500 mg 1 g | $184.00 $245.00 | 13 | |
Ruthenium Red is known to block calcium channels in the cell membrane, which can inhibit TMTC2 by reducing calcium influx if TMTC2's activity is dependent upon calcium signaling. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I is a potent and selective inhibitor of protein kinase C (PKC). If TMTC2 is regulated by PKC-mediated phosphorylation, inhibition of PKC can lead to decreased function of TMTC2. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $94.00 $349.00 | 114 | |
Thapsigargin specifically inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), leading to a depletion of ER calcium stores. If TMTC2 requires ER calcium homeostasis for proper folding or function, this would inhibit its activity. | ||||||
2-APB | 524-95-8 | sc-201487 sc-201487A | 20 mg 100 mg | $27.00 $52.00 | 37 | |
2-Aminoethoxydiphenyl borate (2-APB) inhibits IP3 receptors, which may lead to reduced calcium release from the ER. Reduced calcium signaling could inhibit TMTC2 if its function is linked to calcium signaling. | ||||||
ML-7 hydrochloride | 110448-33-4 | sc-200557 sc-200557A | 10 mg 50 mg | $89.00 $262.00 | 13 | |
ML-7 is an inhibitor of myosin light chain kinase (MLCK). If TMTC2 function is associated with cytoskeletal changes mediated by MLCK activity, inhibition of MLCK would reduce TMTC2 function. | ||||||
BAPTA, Free Acid | 85233-19-8 | sc-201508 sc-201508A | 100 mg 500 mg | $67.00 $262.00 | 10 | |
BAPTA is a calcium chelator that can effectively reduce intracellular calcium levels. If TMTC2 activity is calcium-dependent, chelation of calcium would inhibit its function. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $163.00 $300.00 $1642.00 | 18 | |
W-7 inhibits calmodulin, which is involved in calcium signaling pathways. If TMTC2 is regulated by calmodulin-dependent pathways, inhibition of calmodulin would lead to TMTC2 inhibition. | ||||||
Cyclopiazonic Acid | 18172-33-3 | sc-201510 sc-201510A | 10 mg 50 mg | $173.00 $612.00 | 3 | |
Cyclopiazonic acid is an inhibitor of the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA). Inhibition of SERCA could inhibit TMTC2 by disrupting calcium homeostasis if TMTC2 is sensitive to ER calcium levels. | ||||||
SK&F 96365 | 130495-35-1 | sc-201475 sc-201475B sc-201475A sc-201475C | 5 mg 10 mg 25 mg 50 mg | $101.00 $155.00 $389.00 $643.00 | 2 | |
SKF-96365 inhibits receptor-mediated calcium entry channels and can lead to reduced intracellular calcium levels. If TMTC2 activity is regulated through receptor-mediated calcium signaling, this would inhibit its function. | ||||||